| #28 |
Robert Petit |
Lir France |
1 |
| #28 |
Tzuu-Yi Wang |
AT&T |
1 |
| #28 |
Robert Day |
Trw Limited |
1 |
| #28 |
William J. Pitts |
Bristol-Myers Squibb |
1 |
| #28 |
William A. Kinney |
Aldeyra Therapeutics |
1 |
| #28 |
Douglas Raymond Knoblauch |
— |
1 |
| #28 |
Devin Pellicone |
Advanced Cooling Technologies |
1 |
| #28 |
Michael Grudsky |
Honeywell |
1 |
| #28 |
Thomas E. Martin |
Genzyme |
1 |
| #28 |
Peng Zhou |
Rheonix |
1 |
| #28 |
John V. Duncia |
Bristol-Myers Squibb |
1 |
| #28 |
Jignesh Patel |
Cox Communications |
1 |
| #28 |
Paul K. Wotton |
Antares Pharma |
1 |
| #28 |
Marvin B. Cohen |
Agios Pharmaceuticals |
1 |
| #28 |
Frank S. Krufka |
Rca |
1 |
| #28 |
Guoyang Xu |
Princeton Optronics |
1 |
| #28 |
Michael Amatangelo |
Bristol-Myers Squibb |
1 |
| #28 |
Jan E. Shulman |
Rohm And Haas |
1 |
| #28 |
Michael Korsky |
Bath Authority |
1 |
| #28 |
Nathaniel David Kopp |
Bristol-Myers Squibb |
1 |
| #28 |
William Borchert |
— |
1 |
| #28 |
Guanglin Luo |
Bristol-Myers Squibb |
1 |
| #28 |
Donn Molineux |
— |
1 |
| #28 |
Fu Chen |
Betz Laboratories |
1 |
| #28 |
Scott Hanslip |
Iqvia |
1 |
| #28 |
Brenda CIRINCIONE |
Vertex Pharmaceuticals Incorporated |
1 |
| #28 |
Stuart Myles |
Amazon |
1 |